tirzepatide: How we help you choose Both medications can support weight loss, but the right fit depends on your goals, health history, labs, budget, and response to treatment
But the promise of potentially injectable monthly regimens and a complementary mechanism (amylin) was enough to spark a hot race
However, that weight loss may depend on how well the individual follows the treatment plan and other lifestyle changes incorprotated
What TRIUMPH Tells Us About Duration Specifically The 68-week TRIUMPH-4 data extends our window of safety observation by nearly five months compared to Phase 2
A whole slew of next-generation obesity drugs are on the horizon, some already advanced enough in clinical trials to be looking as good asif not better thanthose already on the market
Sodium-glucose co-transporter-2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: a nationwide population-based cohort study